Caxton Associates »

Supernus Pharmaceuticals shares owned by Caxton Associates

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Caxton Associates from 13F filings

Historical chart of Caxton Associates investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Caxton Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Caxton Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 23k 47.79

More positions owned by Caxton Associates

Tesla Motors (TSLA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Intel Corporation (INTC)
Kellogg Company Put Option (K)
Ishares Msci Mexico Etf (EWW)
Uranium Energy (UEC)
Ishares Msci Brazil Etf (EWZ)
Cameco Corporation (CCJ)
Netflix (NFLX)
Frontier Communications Pare (FYBR)
Kraneshares Trust Csi Chi Internet (KWEB)
Sandisk Corp Put Option (SNDK)

View all positions for Caxton Associates

Top funds holding Supernus Pharmaceuticals

BlackRock
Vanguard Group
Dimensional Fund Advisors
Armistice Capital
Macquarie Group
State Street Corporation
Point72 Asset Management
Renaissance Technologies
Citadel Advisors
Geode Capital Management
Stephens Investment Management Group
Loomis, Sayles and
Woodline Partners
Goldman Sachs Group
Jennifer Ranahan

View all funds holding Supernus Pharmaceuticals